TP53 and breast carcinoma: Altered ribosome biogenesis also concurs to the altered translational activity of cancer cells; for example, it has been observed that in the aggressive breast cancer cell line MA-, 43S pre-rRNA was abnormal, resulting in an impaired ability to initiate p53 cap-independent translation via IRES48.